Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — Q3 2020 Earnings Presentation
13 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Oct 29, 2020
Slide 1: Q3 Conference Call
Q3 Conference Call Drägerwerk AG & Co. KGaA Lübeck, October 29, 2020
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Business Highlights
Business Highlights − Corona pandemic boosts 2020 order entry for intensive care medical products as well as light breathing protection in safety. Q3 demand softer than in Q2, but still on high levels. “Non-Covid” product areas continue to be negatively affected by the deteriorating economic environ
Slide 4: Order Development in 9M
Order Development in 9M Order entry (€ million) Group Americas Europe AAA Net Sales + 21.0% + 44.6% + 5.4% Safety 999 +32% +6.1% +68% + 49.4% + 88.5% + 45.0% +34.4% Medical 2,040 Group 3,039 +54% + 39.8% +69.6% + 32.4% +23.6% Growth rates are net of currency effects 4
Slide 5: Business development Group
Business development Group Net Sales Order entry 9M 2019 9M 2020 fx-adj. +35.7% +23.6 Europa 1,096.7 1,848.7 69.6 Currency Currency Americas 388.6 509.5 39.8 adjusted adjusted +30.1% +20.7% AAA 530.8 681.0 32.4 nominal nominal Group 2,016.1 3,039.2 54.1 663 863 1,899 2,291 − Strong order entry in th
Slide 6: Business development Medical
Business development Medical Net Sales Order entry 9M 2019 9M 2020 fx-adj. +54.9% +34.4% Currency Currency Europa 625.2 1,171.5 88.5 adjusted adjusted Americas 256.5 357.9 49.4 +48.1% +31.0% nominal nominal AAA 362.9 510.4 45.0 603 1,532 Medical 1,244.6 2,039.8 67.8 407 1,169 − COVID-19 drives excep
Slide 7: Business development Safety
Business development Safety Net Sales Order entry 9M 2019 9M 2020 fx-adj. +5.1% +6.1% Europa 471.5 677.2 44.6 Currency Currency adjusted adjusted Americas 132.0 151.6 21.0 +1.6% +4.0% nominal nominal AAA 167.9 170.6 5.4 256 260 Safety 771.4 999.4 32.0 730 759 − Strong increase in demand for light br
Slide 8: Key figures
Key figures 9M 2019 9M 2020 Change € million € million % Cashflow (from operating activities) 77.4 93.7 21.0 Investments 88.1 113.4 28.7 Cash and cash equivalents1 196.3 213.0 8.5 Net financial debt1 150.8 491.7 >+100 Net financial debt 1 /EBITDA 2 0.7 1.2 Capital employed 1 1,431.7 1,525.8 6.6 ROCE
Slide 9: Outlook 2020
Outlook 2020 Middle to upper end of net sales and EBIT guidance range EXPECTATIONS FOR FISCAL YEAR 2020 2019 2020e 5.9% 14.0 - 22.0 % Net sales (net of currency effects) (net of currency effects) EBIT margin 2.4% 7.0 - 11.0 % 1 Dräger Value Added EUR -32.7 million EUR 110 - 260 Mio. 1 Based on excha
Slide 10: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA
Slide 11: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. - March 4, 2021 Final 2020 figures - Conference call - April 29, 2021 Report for the first three months 2021 Confer
Slide 12: Contact
Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88
Slide 13: Thank you
Thank you Drägerwerk AG & Co. KGaA 13
Drägerwerk AG & Co. KGaA — Q3 2020 Earnings Presentation on 6ix